首页> 外文期刊>Clinical and experimental ophthalmology >Photodynamic therapy with double duration for circumscribed choroidal haemangioma: functional and anatomical results based on initial parameters
【24h】

Photodynamic therapy with double duration for circumscribed choroidal haemangioma: functional and anatomical results based on initial parameters

机译:具有双重脉络膜血管瘤的双持续时间的光动力疗法:基于初始参数的功能和解剖结果

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Abstract Importance Pre‐treatment symptoms longer than 12?months and foveal cystoid changes are indicators for poor anatomical and functional outcome after photodynamic therapy (PDT). Background To evaluate the prognostic factors on the effectiveness of PDT with double duration for treatment of exudative circumscribed choroidal haemangioma. Design Retrospective study. Participants Twenty‐seven patients with symptomatic exudative circumscribed choroidal haemangioma treated with PDT. Methods Clinical charts of patients with exudative circumscribed choroidal haemangioma treated with PDT were analysed with regard to visual acuity , duration of symptoms, subfoveal fluid, foveal cystoid changes and foveal thickness in optical coherence tomography. Main Outcome Measures Change of best‐corrected visual acuity, sub‐ and intrafoveal fluid and foveal thickness measured with optical coherence tomography from baseline to last follow‐up. Results Mean visual acuity improved by 0.05 from 0.42 logMAR (standard deviation [SD] 0.34) to 0.37 logMAR (SD 0.47). In 70% of the patients, PDT stopped exudation and revealed a dry fovea. The recurrence or persistence of sub‐ or intrafoveal fluid was significantly associated with pre‐therapeutic symptoms existing for more than 12?months ( P ?=?0.046). Mean foveal thickness in optical coherence tomography decreased from 324?μm (SD 223?μm) to 209?μm (SD 109?μm). Conclusions and Relevance PDT proved to be a safe and effective treatment procedure for exudative circumscribed choroidal haemangioma in our series, with few side effects. We observed a more successful treatment with regard to anatomical and functional results in cases with pre‐existing symptoms less than 12?months and in cases without pre‐therapeutic foveal cystoid changes.
机译:摘要重视前治疗症状长于12个月,硬脑芯绿囊骨质变化是光动力治疗(PDT)后解剖和功能结果差的指标。背景,以评价PDT效能性的预后因素,治疗渗出性突出的脉络膜血管瘤的双持续时间。设计回顾性研究。参与者二十七名患有PDT治疗的症状渗透性脉络膜血管瘤。方法采用PDT治疗的渗出性外围脉络膜瘤患者的临床图表在视力,症状持续时间,患者的持续时间,子卵泡液,心液相干断层扫描中的变形厚度。主要结果测量最佳矫正视力的变化,具有从基线到最后一次随访的光学相干断层扫描测量的最佳矫正视力的变化,子腔室和沟槽厚度。结果意味着视力从0.42 logmar改善0.05(标准偏差[SD] 0.34)至0.37 logmar(SD 0.47)。在70%的患者中,PDT停止渗出并显示出干燥的软骨。亚或胸腔内液的复发或持续性与超过12个月的治疗前症状显着相关(p?= 0.046)。光学相干性断层扫描的平均芯片厚度从324Ω·μm(SD223≤μm)降至209ΩΩ/米(SD109≤μm)。结论和相关性PDT被证明是我们系列中渗出的危险脉络膜血管瘤的安全有效治疗程序,副作用少。我们观察到在预先存在的症状小于12?几个月的情况下,在没有预治中的心脏阴囊状的情况下,在患有症状的病例和功能结果方面更成功的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号